Predictive variables of sustained virological response after early discontinuation of triple therapy with telaprevir for genotype-1 HCV infection.

doi:10.1016/j.gastrohep.2015.10.005

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Predictive variables of sustained virological response after early discontinuation of triple therapy with telaprevir for genotype-1 HCV infection.

Gastroenterologia y hepatologia - 1 Jan 2000

Acero Fernández Doroteo, Morillas Cunill Rosa, Ferri Iglesias María José, Torras Collell Xavier, Vergara Gómez Mercedes, Zaragoza Velasco Natividad, López Nuñez Carmen, Forné Bardera Montserrat, Delgado Gómez Mercedes, Barenys Lacha Mercè, Torres Salinas Miquel, Villar Fernández Margarita, Durández Lázaro Rosa, Mariño Mendez Zoe

Abstract excerpt

BACKGROUND: Pivotal phase studies of telaprevir (TLV) and boceprevir (BOV) showed 10-56% rates of early treatment interruption. However, there have been no reports on the sustained virological response (SVR) rates of these patients. AIM: To assess the SVR rate in a large cohort of patients who discontinued triple therapy with TLV or BOV for reasons other than stopping rules and to identify variables predicting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Health Care Surveys

Share to Hepatitis C, Chronic

Share to Oligopeptides

Share to Proline

Share to Sustained Virologic Response

Share to Viremia

Source

Open in PubMed

Identifiers

PMID: 26614733
DOI: 10.1016/j.gastrohep.2015.10.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive variables of sustained virological response after early discontinuation of triple therapy with telaprevir for genotype-1 HCV infection.PMID 26614733Read ↗

A real life boceprevir use in treatment-experienced HCV genotype 1 patients with advanced fibrosis.Semantic proximity Read ↗

Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment.Semantic proximity Read ↗

Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.Semantic proximity Read ↗

Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin.Semantic proximity Read ↗

[Clinical use of telaprevir: stopping rules, predicting response, treatment length, and management of adverse effects].Semantic proximity Read ↗

Efficacy and safety of telaprevir, pegylated interferon α-2b and ribavirin triple therapy in Japanese patients infected with hepatitis C virus genotype 1b.Semantic proximity Read ↗

Factors associated with treatment interruption for Hepatitis C.Semantic proximity Read ↗

Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting.Semantic proximity Read ↗

Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin.Semantic proximity Read ↗

High rates of early treatment discontinuation in hepatitis C-infected US veterans.Semantic proximity Read ↗

Predictors of early treatment discontinuation among patients with genotype 1 hepatitis C and implications for viral eradication.Semantic proximity Read ↗

The importance of HCV RNA measurement for tailoring treatment duration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.